Edvinsson L, Adamsson M, Jansen I
Department of Experimental Research, Malmö General Hospital, Sweden.
Neuropeptides. 1990 Oct;17(2):99-105. doi: 10.1016/0143-4179(90)90056-5.
The antagonistic properties on neuropeptide Y (NPY)-induced contraction of the guinea pig basilar artery of D-myo-inositol-1.2.6-triphosphate (PP56) has been examined using a sensitive in vitro system. It was observed that PP56 did not per se cause contraction or relaxation of precontracted vessel segments. However, it was found to be a non-competitive antagonist of NPY-induced contraction. This effect was observed in the concentration range 10(-8)-10(-6) M PP56. A slight potentiation of endothelin I-induced contraction was seen at high concentrations (10(-3) M). In contrast there was no modulation of the contractile effects elicited by bradykinin, noradrenaline, 5-hydroxytryptamine (5-HT) or prostaglandin F2 alpha (PGF2 alpha) apart from a slight reduction in maximum effect at 10(-4) M and 10(-3) M PP56. PP56 was observed to possess antihistaminic and anticholinergic properties in the concentration range 10(-5) M-10(-3) M. The relaxant effects of vasoactive intestinal peptide, calcitonin gene-related peptide, neurokinin A and substance P were only modified to a minor extent by PP56 in concentrations of 10(-4) M and 10(-3) M. In conclusion, PP56 appears to be the first non-peptide which potently and rather selectively antagonizes NPY-induced contractions of the guinea pig basilar artery. In high concentrations, PP56 may modify the responses of other agents tested, including histamine and acetylcholine.
使用灵敏的体外系统研究了D-肌醇-1,2,6-三磷酸(PP56)对豚鼠基底动脉中神经肽Y(NPY)诱导收缩的拮抗特性。观察到PP56本身不会引起预收缩血管段的收缩或舒张。然而,发现它是NPY诱导收缩的非竞争性拮抗剂。在10^(-8)-10^(-6) M PP56的浓度范围内观察到了这种效应。在高浓度(10^(-3) M)时,观察到内皮素I诱导的收缩有轻微增强。相比之下,除了在10^(-4) M和10^(-3) M PP56时最大效应略有降低外,缓激肽、去甲肾上腺素、5-羟色胺(5-HT)或前列腺素F2α(PGF2α)引起的收缩效应没有受到调节。在10^(-5) M-10^(-3) M的浓度范围内,观察到PP56具有抗组胺和抗胆碱能特性。血管活性肠肽、降钙素基因相关肽、神经激肽A和P物质的舒张作用在10^(-4) M和10^(-3) M浓度的PP56作用下仅受到轻微改变。总之,PP56似乎是第一种有效且相当选择性地拮抗豚鼠基底动脉中NPY诱导收缩的非肽类物质。在高浓度时,PP56可能会改变其他受试药物(包括组胺和乙酰胆碱)的反应。